Skip to main content

Induction of labor compared to expectant management in term nulliparas with a latent phase of labor of more than 8 hours: a randomized trial



Prolonged latent phase of labor is associated with adverse maternal and neonatal outcomes. Preliminary data indicate that labor induction for prolonged latent phase may reduce cesarean delivery. We performed a study powered to Cesarean delivery to evaluate labor induction compared to expectant management in full term nulliparas hospitalized for persistent contractions but non-progressive to established labor after an overnight stay.


From 2015 and 2017, nulliparas, ≥ 39 weeks’ gestation with prolonged latent phase of labor (persistent contractions after overnight hospitalization > 8 h), cervical dilation ≤3 cm, intact membranes and reassuring cardiotocogram were recruited. Participants were randomized to immediate induction of labor (with vaginal dinoprostone or amniotomy or oxytocin as appropriate) or expectant management (await labor for at least 24 h unless indicated intervention as directed by care provider). Primary outcome measure was Cesarean delivery.


Three hundred eighteen women were randomized (159 to each arm). Data from 308 participants were analyzed. Cesarean delivery rate was 24.2% (36/149) vs. 23.3%, (37/159) RR 1.0 95% CI 0.7–1.6; P = 0.96 in induction of labor vs. expectant arms. Interval from intervention to delivery was 17.1 ± 9.9 vs. 40.1 ± 19.8 h; P < 0.001, intervention to active labor 9.6 ± 10.2 vs. 29.6 ± 18.5 h; P < 0.001, active labor to delivery 7.6 ± 3.6 vs. 10.5 ± 7.2 h; P < 0.001, intervention to hospital discharge 2.4 ± 1.2 vs. 2.9 ± 1.4 days; P < 0.001 and dinoprostone use was 19.5% (29/149) vs. 8.2% (13/159) RR 2.4 95% CI 1.3–4.4; P = 0.01 in IOL compared with expectant arms respectively. Intrapartum oxytocin use, epidural analgesia and uterine hyperstimulation syndrome, postpartum hemorrhage, patient satisfaction on allocated intervention, during labor and delivery and baby outcome were not significantly different across trial arms.


Induction of labor did not reduce Cesarean delivery rates but intervention to delivery and to hospital discharge durations are shorter. Patient satisfaction scores were similar. Induction of labor for prolonged latent phase of labor can be performed without apparent detriment to expedite delivery.

Trial registration

Registered in Malaysia National Medical Research Register (NMRR-15-16-23,886) on 6 January 2015 and the International Standard Randomised Controlled Trials Number registry, registration number ISRCTN14099170 on 5 Nov 2015.

Peer Review reports


The conventional understanding is that latent phase of labor can last for 20 h and begins when the cervix starts to dilate from 0 to 3 cm or 4 cm and contractions get stronger [1]. More recently according to National Institute of Clinical Excellence UK, the latent phase starts when there are contraction pain, not necessarily continuous accompanied by some cervical effacement and dilation up to 4 cm [2]. Women experienced their onset of labour in a variety of ways and a large proportion of these experiences bore no resemblance to the classical diagnosis of labor and most were unrelated to the duration of labor [3].. Recent studies showed that in predominantly white, healthy nulliparas, duration of the latent phase of labor was a median duration 9.0 h and mean 11.8 h [4] and self-reported prolonged latent phase that lasted 18 h or more occurred in 29.2% of nulliparas [5]. In Chinese nulliparas, singleton term gestation, spontaneous onset of labor, vaginal delivery, and a normal perinatal outcome, latent phase of labor was 5.1 ± 3.2 h [6]. There was no consensus on the definition of a prolonged latent phase of labor or even of labor onset in the research literature [7].

Friedman [8] introduced the relationship between duration of labor and cervical dilatation as a sigmoid curve [1]. More recently, Zhang et al. noted that the pattern of labor progression among nulliparous women in contemporary practice differed significantly from Friedman’s curve with the transition from latent to active phases of labor appearing more gradually [9]. Recently, it has been recognised that the active phase often did not start until at least 6 cm [10] but women whose dilation time from 4 cm to 6 cm exceeds the 90th percentile have increased odds of cesarean delivery and postpartum complications [11]; in nulliparous labor induction cesarean delivery (for failed induction) should not be undertaken during the latent phase prior to at least 15 h after oxytocin and rupture of membranes have occurred [12].

Prolonged latent phase was independently associated with an increased incidence of subsequent labor abnormalities, need for cesarean delivery, depressed Apgar scores, and need for newborn resuscitation [13], and also with oxytocin augmentation, thick meconium staining and admission to the neonatal unit [14];childbirth experience was also negatively affected [15].

In our centre, women who presented in latent phase of labor were typically offered hospitalization. For term women, if active labor had not occurred after an overnight stay and contractions persisted, management the following morning depended on provider and patient preference, with labor induction more likely at full term compared to expectant management.

In a 2014 trial report on 129 nulliparous women with prolonged latent phase of labor, the Cesarean section rate was 15/65 (23.1%) with early induction and 24/64 (37.5%) with expectant management P = 0.076 (power 45%) [16]. We undertook a powered study based on the aforementioned findings to evaluate labor induction compared to expectant management on Cesarean delivery rate as primary outcome in nulliparas who are at higher risk of Cesarean delivery with labor induction [17].


This was a randomized controlled trial conducted in a University hospital in Malaysia, with the first participant recruited on 5 June, 2015 and the last on 10 November 2017. Our delivery unit was located within a tertiary referral facility with about 5000 deliveries per year and an overall Cesarean delivery rate of 30%. The trial was approved by the Medical Ethics Committee of University Malaya Medical Center (date of approval: 25 February 2015; reference number: 20151–971) and registered in the online searchable Malaysian National Medical Research Register (no. NMRR-15-16-23,886; on 6 January 2015 before trial enrolment. Malaysian research regulations governing public health institutions requires NMRR registration after a ‘preliminary’ ethics approval with ethics approval formalized after the issue of an NMRR number. In addition, the trial was also registered in the International Standard Randomised Controlled Trials Number registry, registration number ISRCTN14099170 ( on 5 Nov 2015 as Malaysian NMRR might be unrecognized. The trial was conducted in accordance with the Declaration of Helsinki on human experimentation. The study adhered to CONSORT guidelines.


Inclusion criteria were prolonged latent phase of labor (defined as an overnight hospitalization of at least 8 h for latent phase of labor), persistent contractions of at least 1 in 30 min, cervical dilation ≤3 cm and intact membranes, nulliparous (no prior pregnancy > 20 weeks), a singleton fetus, cephalic presentation, reassuring fetal heart rate tracing and ≥ 39 weeks’ gestation. Exclusion criteria included known fetal abnormalities, estimated fetal weight ≥ 4 kg or ≤ 2 kg (clinical assessment for small or large for gestational age, if either suspected then ultrasound estimation of fetal weight), contraindications to expectant management (e.g. pregnancy induced hypertension, suspected abruptio), previous uterine surgery (e.g. myomectomy or hysterotomy), known prostaglandin allergy or contraindication to vaginal delivery.

Eligible women were approached, provided with the patient information sheet, verbally counselled, and written informed consent were taken from women who agreed to participate by co-investigators LLMB and subsequently PS on investigator availability. Pre-intervention assessments were Bishop scoring by care provider, fetal heart rate tracing, and visual numerical rating scale (VNRS 0 to 10, higher score more pain) contraction pain score. Participants’ relevant demographic and clinical data were transcribed onto the Case Report Form.

Randomization and allocated intervention

Participants were randomized to induction of labor or expectant management (for at least 24 h or until indicated intervention according to care provider) by the opening of the lowest numbered sealed, numbered and opaque envelop remaining. Envelopes were prepared using a computer generated random sequence using by an investigator who was not involved in the trial recruitment.

Induction of labor was undertaken according to care provider preference taking into account cervical favorability and frequency of contractions. Common methods we used were amniotomy with or without immediate titrated oxytocin infusion, titrated oxytocin infusion [18] or vaginal dinoprostone pessary [19].

In the expectant management group, spontaneous onset of active phase of labor (defined as regular contractions with cervical dilation > 4 cm) was awaited for at least 24 h; active management including labor induction might be carried based on provider and patient consensus thereafter.

Sample size

A previous trial has shown Cesarean delivery rates of 23.1% vs 37.5% in the early induction group vs. the expectant management group [16]. Applying alpha 0.05, power 80%, 1 to 1 trial arm ratio and applying the Chi Square test, 159 patients were needed in each arm.

Outcomes measures

The primary outcome was Cesarean delivery. Secondary maternal outcomes were labor duration outcomes (intervention to active phase of labor i.e. cervical dilation ≥5 cm and to delivery), epidural analgesia needed, intrapartum oxytocin, uterine hyperstimulation syndrome (non-reassuring fetal heart tracing concurrent with uterine tachysystole ≥6 contraction in 10 min), postpartum hemorrhage (blood loss ≥500 ml) and patient’s satisfaction (Likert response) to allocated intervention, during delivery and baby outcome obtained after delivery before hospital discharge. Secondary neonatal outcomes were 5-min Apgar score below 7, cord artery metabolic acidosis (pH ≤ 7 and BE [base excess] ≤ − 8 mmol/L), birth weight and admission to the neonatal intensive care unit (NICU) and admission indications.

Statistical analysis

Data were entered into a statistical software package SPSS (Version 23, IBM Corp, Armonk, NY). The Student t test was used to analyse means and continuous data and chi-square test for categorical data. Two-sided P values were reported, and a P value of < 0.05 for all variables was regarded as significant.

Ethical aspects

Women who chose not to participate received standard care and participants who decided to withdraw may do so without having to give a reason and their care was not affected. Participants were not remunerated.


Figure 1 depicts the recruitment flow of trial participants. Of 321 eligible women approached, 3 declined participation; 318 women were randomized (158 to labor induction and 160 to expectant management). Due to criteria infringements, we excluded nine women allocated to labor induction due to 1) labor induction refusal (four women), 2) membranes already ruptured (three women) and 3) pre-induction non-reassuring fetal heart rate tracing (two women) and one woman assigned to expectant management due to membranes already ruptured.

Fig. 1

Recruitment flow chart into a randomized trial of induction of labor compared to expectant management in term nulliparas with a latent phase of labor of more than 8 hours

Table 1 depicts the characteristics of the participants stratified according to randomization to early induction or expectant management. Characteristics including of the Bishop score were similar across trial arms.

Table 1 Characteristics of trial participants

Table 2 depicts the primary outcomes analysis: Cesarean delivery (vs. vaginal delivery) rates were 24.2% (36/149) vs. 23.3% (37/159) RR 1.0 95% CI 0.7–1.6, P = 0.96; the spontaneous vaginal delivery rates 55.0% (82/149) vs. 56.6 (90/159), instrumental (forceps or vacuum) vaginal delivery rates were 20.8% (31/149) vs. 20.1% (32/159), P = 0.88 (3 by 2 Chi Square analysis) for labor induction vs. expectant arms respectively. Cesarean delivery indications were also similar across trial arms.

Table 2 Primary Outcomes

Table 3 depicts the secondary maternal and Table 4 the neonatal outcomes. Intervention to delivery as expected were significantly shorter in the induction of labor arm 17.1 ± 9.9 vs 40.1 ± 19.8 h P < 0.001, with both the intervention to active labor and active labor to delivery intervals also significantly shorter in the labor induction arm 9.6 ± 10.2 vs 29.6 ± 18.5 h P < 0.001 and 7.6 ± 3.6 vs. 10.5 ± 7.2 h P < 0.001 respectively. Intervention to hospital discharge interval was also significantly shorter in the labor induction arm 2.4 ± 1.2 vs. 2.9 ± 1.4 days P < 0.001 but the delivery to hospital discharge is significantly longer 1.4 ± 1.2 vs. 1.0 ± 1.3 days P = 0.03. As expected the use of vaginal dinoprostone for labor induction was higher in the labor induction arm 19.5% (29/149) vs 8.2% (13/159) RR 2.4 95% CI 1.3–4.4 P = 0.01 but oxytocin use in labor was only not significantly higher 55.7% (83/149) vs 47.8% (76/159) RR 1.4 95% CI 0.9–2.2 P = 0.17. Other maternal outcomes of intrapartum epidural analgesia, uterine hyperstimulation syndrome, postpartum hemorrhage and Likert scale satisfaction responses on allocated intervention, labor and delivery and baby outcomes were similar across trial arms. Secondary neonatal outcomes of Apgar score at 5 min, umbilical cord artery pH and base excess, birth weight, neonatal admission and indications were not significantly different across trial arms.

Table 3 Secondary Outcomes
Table 4 Secondary Outcomes

Sensitivity analysis

Post randomization, there were nine exclusions in the labor induction arm, and one in the expectant management arm. Assuming worst case scenario that all nine excluded women in the labor induction arm had Cesarean delivery and the excluded woman in the expectant arm had a vaginal delivery, the Cesarean delivery rates across trial arms were still not significantly different; 45/158 (28.4%) vs. 37/160 (23.1%) P = 0.29.


Our trial did not demonstrate a reduction in Cesarean delivery rate in the labor induction arm; the point estimate for Cesarean delivery marginally favored the expectant management arm in contrast to our hypothesis. The point estimate from our data in the opposite direction to our hypothesis indicate that a further increase in sample size is unlikely to bolster support for our hypothesis derived from Brane et al [16] and hence futile. A retrospective study (which did not adjust for risk characteristics) shows that nulliparas having a prolonged latent phase and remaining in hospital had fewer spontaneous vaginal births, more emergency CSs and more babies with Apgar < 7 at 5 min compared with those returning home [20] potentially inconsistent to the finding that women indicating that they had been in labour for 24 h or longer at the time of hospital admission were at elevated risk for cesarean birth and meconium-stained amniotic fluid [21] and a stark contrast to the beneficial interventionist approach of Brane et al. [16]

The recent Arrive trial of labor induction at 39 weeks’ gestation vs. expectant management in low risk nulliparas showed a significant reduction in Cesarean delivery rate, pain at delivery, greater perceived control during childbirth but a non-significant reduction in composite neonatal morbidity with labor induction [22]. Our trial finding of very similar Cesarean delivery rate and similar patient satisfaction with early labor induction is in contrast to the Arrive trial [22] but our and their populations’ presentations were quite different albeit all were nulliparas; our trial is not powered to evaluate neonatal outcomes.

In the seminal TermProm trial, amongst nulliparas, Cesarean delivery rates were 14.1% vs 13.7% (induction with oxytocin vs expectant management then oxytocin induction if required) and 13.7% vs. 15.2% (induction with prostaglandin management vs. expectant management then prostaglandin induction if required) [23]: the Cesarean delivery rates for labor induction and expectant management were very similar, consistent with our finding in nulliparas with prolonged latent phase of labor. However our overall Cesarean delivery rate of 24% is higher than the 14% overall rate in the TermProm trial. Cesarean delivery rates were 23.1% vs 37.5% for labor induction group vs. expectant management for prolonged latent phase of labor participants in Brane et al. [16].

A study from our centre on the labour induction of nulliparas at term with unfavorable cervixes demonstrated that maternal satisfaction is associated with a shorter induction-to-delivery interval [24]. A very recent study also found that women’s perception of quality of intrapartum care, the birth experience and feelings were related to length of the latent phase of labour [25]. In this trial, despite significantly shorter intervention to delivery (both components of intervention to active labor and active labor to delivery intervals being significantly shorter when considered separately), women assigned to labor induction were not significantly more satisfied with their allocated intervention assessed to delivery and on baby outcome; indeed the point maternal satisfaction point estimates to delivery and on baby outcome non-significantly favored the expectant management arm. The lack of a significant correlation of maternal satisfaction to intervention to delivery interval in this trial was unexpected and seemingly difficult to understand as intervention to active labor was prolonged by a considerable mean 23 h with expectant management but satisfaction may be counterbalanced by the significantly longer delivery to hospital discharge in the labor induction arm. It should also be noted that 4/158 (2.5%) of women randomized to labor induction refused their allocated intervention and withdrew from the study which indicated that a small number of women showed resistance to labor induction compared to letting events take their natural course when contractions had already started. However, assessing satisfaction is a complex process and we had not covered these secondary satisfaction outcomes comprehensively with the use of one-dimensional questions. A recent qualitative study shows that nulliparas with a prolonged latent phase of labor preferred woman-centred care with midwives playing an important role in support and the need for support increases as the time spent in latent phase increases [26]. A recent metasynthesis of the literature on first-time mothers’ experiences of early labour suggested that women’s needs when planning a hospital birth were not being adequately met at this stage of the labour process. These considerations which were not covered in our trial could plausibly influence participants’ satisfaction.

In our centre, the overall Cesarean delivery rate after “cold” labor induction of nulliparas with unfavorable cervixes was 42–45% [24]. The 23–27% Cesarean delivery in this trial indicates that our current population of women in prolonged latent phase was in a lower risk group for Cesarean delivery than in “cold case” nulliparous labor induction probably due to a generally more favorable cervix at the start, plausibly to a maternal environment more amenable to respond well to induction of labor and comprising healthier women who did not have a conventional indication for labor induction at their presentation and hospital admission.

Strengths and limitations

As to strength of our trial, Brane [16] defined prolonged latent phase as presence of contraction (based on women’s perception) for more than 18 h with cervical dilatation of 4 cm or less. Our definition of prolonged latent phase of labor is defined by persistent contraction after an overnight hospital stay, a more practical categorization as in routine practice, care planning and decision making are usually undertaken at the morning round. Our study is powered to Brane et al’s finding [16] but differences in inclusion criteria might have contributed to our trial’s finding of similar Cesarean delivery rates across our trial arms in contrast to theirs that favored labor induction.

As to limitations, we were not able to mask interventions due to intrinsic nature of the interventions. We had a small number of post randomization drop-outs which reduced power; however sensitivity analysis assuming worst case scenario did not materially change the finding of no significant difference in primary outcome Cesarean delivery rate across trial arms. Our trial population might also represent a number of mislabelled “prolonged latent phase of labor” who might actually be cases of false labour or in normal latent phase as our qualifying threshold duration for uterine contractions could be shorter than Friedman’s 20 h [1, 8]. Any labor induction in the expectant management arm soon after the 24 h of prohibition might have reduced power as the difference between the interventions would be less distinct. Participants in the trial were probably a minority of potentially eligible women through our trial enrolment period as our screening and recruitment process was not comprehensive with the possibility for recruitment bias.


Nulliparas at full term in prolonged latent phase of labor should be informed that labor induction compared with expectant management is associated with a significantly shorter intervention to delivery interval but Cesarean delivery, patient satisfaction and neonatal outcomes are not significantly different compared to expectant management to aid their decision making on management.

Availability of data and materials

All data generated or analysed during this study are included in this published article and the datasets used are available from the corresponding author on reasonable request.



Base excess


Neonatal intensive care unit


United Kingdom


  1. 1.

    Friedman EA. An objective approach to the diagnosis and management of abnormal labor. Bull N Y Acad Med. 1972;48(6):842–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2.

    NICE: Intrapartum care for healthy women and babies. National Institute for Health and Care Excellence clinical guideline 2014; niceorguk/guidance/cg190.

    Google Scholar 

  3. 3.

    Gross MM, Hecker H, Matterne A, Guenter HH, Keirse MJ. Does the way that women experience the onset of labour influence the duration of labour? BJOG. 2006;113(3):289–94.

    Article  Google Scholar 

  4. 4.

    Tilden EL, Phillippi JC, Ahlberg M, King TL, Dissanayake M, Lee CS, Snowden JM, Caughey AB. Describing latent phase duration and associated characteristics among 1281 low-risk women in spontaneous labor. Birth. 2019;46(4):592–601.

    Article  Google Scholar 

  5. 5.

    Angeby K, Wilde-Larsson B, Hildingsson I, Sandin-Bojo AK. Prevalence of prolonged latent phase and labor outcomes: review of birth records in a Swedish population. J Midwifery Womens Health. 2018;63(1):33–44.

    Article  Google Scholar 

  6. 6.

    Chen H, Cao L, Cao W, Wang H, Zhu C, Zhou R. Factors affecting labor duration in Chinese pregnant women. Medicine (Baltimore). 2018;97(52):e13901.

    Article  Google Scholar 

  7. 7.

    Hanley GE, Munro S, Greyson D, Gross MM, Hundley V, Spiby H, Janssen PA. Diagnosing onset of labor: a systematic review of definitions in the research literature. BMC Pregnancy Childbirth. 2016;16:71.

    Article  Google Scholar 

  8. 8.

    Friedman EA, Sachtleben MR. Dysfunctional labor. I. Prolonged latent phase in the nullipara. Obstet Gynecol. 1961;17:135–48.

    CAS  PubMed  Google Scholar 

  9. 9.

    Zhang J, Troendle JF, Yancey MK. Reassessing the labor curve in nulliparous women. Am J Obstet Gynecol. 2002;187(4):824–8.

    Article  Google Scholar 

  10. 10.

    American College of O, Gynecologists, Society for Maternal-Fetal M. Obstetric care consensus no. 1: safe prevention of the primary cesarean delivery. Obstet Gynecol. 2014;123(3):693–711.

    Article  Google Scholar 

  11. 11.

    Rosenbloom JI, Woolfolk CL, Wan L, Stout MJ, Tuuli MG, Macones GA, Cahill AG. The transition from latent to active labor and adverse obstetrical outcomes. Am J Obstet Gynecol. 2019;221(5):487.e1–487.e8.

    Article  Google Scholar 

  12. 12.

    Grobman WA, Bailit J, Lai Y, Reddy UM, Wapner RJ, Varner MW, Thorp JM Jr, Leveno KJ, Caritis SN, Prasad M, et al. Defining failed induction of labor. Am J Obstet Gynecol. 2018;218(1):122 e121–8.

    Google Scholar 

  13. 13.

    Chelmow D, Kilpatrick SJ, Laros RK Jr. Maternal and neonatal outcomes after prolonged latent phase. Obstet Gynecol. 1993;81(4):486–91.

    CAS  PubMed  Google Scholar 

  14. 14.

    Maghoma J, Buchmann EJ. Maternal and fetal risks associated with prolonged latent phase of labour. J Obstet Gynaecol. 2002;22(1):16–9.

    CAS  Article  Google Scholar 

  15. 15.

    Ulfsdottir H, Nissen E, Ryding EL, Lund-Egloff D, Wiberg-Itzel E. The association between labour variables and primiparous women's experience of childbirth; a prospective cohort study. BMC Pregnancy Childbirth. 2014;14:208.

    Article  Google Scholar 

  16. 16.

    Brane E, Olsson A, Andolf E. A randomized controlled trial on early induction compared to expectant management of nulliparous women with prolonged latent phases. Acta Obstet Gynecol Scand. 2014;93(10):1042–9.

    Article  Google Scholar 

  17. 17.

    Laughon SK, Zhang J, Grewal J, Sundaram R, Beaver J, Reddy UM. Induction of labor in a contemporary obstetric cohort. Am J Obstet Gynecol. 2012;206(6):486 e481–9.

    Article  Google Scholar 

  18. 18.

    Nachum Z, Garmi G, Kadan Y, Zafran N, Shalev E, Salim R. Comparison between amniotomy, oxytocin or both for augmentation of labor in prolonged latent phase: a randomized controlled trial. Reprod Biol Endocrinol. 2010;8:136.

    Article  Google Scholar 

  19. 19.

    Hawkins JS, Wing DA. Current pharmacotherapy options for labor induction. Expert Opin Pharmacother. 2012;13(14):2005–14.

    CAS  Article  Google Scholar 

  20. 20.

    Lundgren I, Andren K, Nissen E, Berg M. Care seeking during the latent phase of labour--frequencies and birth outcomes in two delivery wards in Sweden. Sex Reprod Healthc. 2013;4(4):141–6.

    Article  Google Scholar 

  21. 21.

    Janssen PA, Weissinger S. Women's perception of pre-hospital labour duration and obstetrical outcomes; a prospective cohort study. BMC Pregnancy Childbirth. 2014;14:182.

    Article  Google Scholar 

  22. 22.

    Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, et al. Labor induction versus expectant management in low-Risk Nulliparous women. N Engl J Med. 2018;379(6):513–23.

    Article  Google Scholar 

  23. 23.

    Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, Wang EE, Weston JA, Willan AR. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM study group. N Engl J Med. 1996;334(16):1005–10.

    CAS  Article  Google Scholar 

  24. 24.

    Tan PC, Valiapan SD, Tay PY, Omar SZ. Concurrent oxytocin with dinoprostone pessary versus dinoprostone pessary in labour induction of nulliparas with an unfavourable cervix: a randomised placebo-controlled trial. BJOG. 2007;114(7):824–32.

    CAS  Article  Google Scholar 

  25. 25.

    Angeby K, Sandin-Bojo AK, Persenius M, Wilde-Larsson B. Women's labour experiences and quality of care in relation to a prolonged latent phase of labour. Midwifery. 2019;77:155–64.

    Article  Google Scholar 

  26. 26.

    Angeby K, Wilde-Larsson B, Hildingsson I, Sandin-Bojo AK. Primiparous women's preferences for care during a prolonged latent phase of labour. Sex Reprod Healthc. 2015;6(3):145–50.

    Article  Google Scholar 

Download references


We thank the women who participated in the trial and all care providers for their contribution to this trial.


This study was internally funded by University of Malaya research grant (BK078–2015).

Author information




PNS: Data collection (main), data analysis and interpretation (main), manuscript drafting and amendments (support). LLMB: Protocol development (main), data collection (support), manuscript review and amendments (support). PCT: Protocol development (support), data analysis (support) and interpretation (main), manuscript drafting and writing (main). NV: Data interpretation (support), manuscript review and amendments (support). MANA: Protocol development (main), manuscript review and amendments (support). SNZ: Protocol development (support), manuscript review and amendments (support). STW: Data analysis and data interpretation (main), manuscript drafting and writing (support). SZO: Data interpretation (support), manuscript review and amendments support) All authors: Approved the final version to be published.

Corresponding author

Correspondence to Peng Chiong Tan.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of Ethics Committee of University Malaya Medical Centre (Date of approval:25/02/2015, Reference: MECID: 20151–971, Reference: NMRR- 15-16-23886 and registered in ISRCTN registry ( on 5 November 2015, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed written consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sargunam, P.N., Bak, L.L.M., Tan, P.C. et al. Induction of labor compared to expectant management in term nulliparas with a latent phase of labor of more than 8 hours: a randomized trial. BMC Pregnancy Childbirth 19, 493 (2019).

Download citation


  • Cesarean
  • Vaginal delivery
  • Latent phase of labor
  • Induction of labor
  • Expectant management
  • Term
  • Nullipara
  • Patient satisfaction